Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging

European Radiology

Volumn 19, Issue 6, 2009, Pages 1387-1393

  Froehlich, Johannes M ^a   Daenzer, Muriel ^b   von Weymarn, Constantin ^a   Erturk, S Mehmet ^c   Zollikofer, Christoph L ^a   Patak, Michael A ^b  

^a CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Antispasmodic drugs; Gastrointestinal motility; Glucagon; Hyoscine N butylbromide; Magnetic resonance imaging; Small intestine

Indexed keywords

GADOTERATE MEGLUMINE; GADOTERIC ACID; GLUCAGON; ISPAGULA; RECOMBINANT GLUCAGON; SCOPOLAMINE BUTYL BROMIDE;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DIZZINESS; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE QUALITY; INTESTINE CONTRACTION; INTESTINE MOTILITY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SMALL INTESTINE; SPASMOLYSIS;

ADULT; BUTYLSCOPOLAMMONIUM BROMIDE; CONTRAST MEDIA; FEMALE; GLUCAGON; HUMANS; IMAGE ENHANCEMENT; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING; MALE; PARASYMPATHOLYTICS; PERISTALSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 67349157160     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1293-2     Document Type: Article

References (17)

1. Laniado M, Gronewaller E, Kopp AF, Kaminsky SF, Hamm B, Jacobsen TF, Claussen CD (1997) The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Abdom Imaging 22:381-388
2. Kozak RI, Bennett JD, Brown TC, Lee TY (1994) Reduction of bowel motion artifact during digital subtraction angiography: A comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J 45:209-211
3. Hupscher DN, Dommerholt O (1984) Action and side effects of small doses of buscopan in gastroduodenal radiography. A prospective study in 300 patients. Diagn Imaging Clin Med 53:77-86
4. Tytgat GN (2007) Hyoscine butylbromide: A review of its use in the treatment of abdominal cramping and pain. Drugs 67:1343-1357
5. Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, Drucker DJ (2003) International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167-194
6. Froehlich JM, Patak MA, von Weymarn C, Juli CF, Zollikofer CL, Wentz KU (2005) Small bowel motility assessment with magnetic resonance imaging. J Magn Reson Imaging 21:370-375
7. Johnson W, Taylor MB, Carrington BM, Bonington SC, Swindell R (2007) The value of hyoscine butylbromide in pelvic MRI. Clin Radiol 62:1087-1093
8. Marti-Bonmati L, Graells M, Ronchera-Oms CL (1996) Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: A comparative evaluation of three drugs. Abdom Imaging 21:309-313
9. Wagner M, Klessen C, Rief M, Elgeti T, Taupitz M, Hamm B, Asbach P (2008) High-resolution T2-weighted abdominal magnetic resonance imaging using respiratory triggering: Impact of butylscopolamine on image quality. Acta Radiol 49:376-382
10. Cittadini G, Sardanelli F, De Cicco E, Casiglia M, De Cata T, Parodi RC (1998) Compared effect of a genetically engineered glucagon and hyoscine N-butylbromide on double-contrast barium meal study. Eur Radiol 8:449-453
11. Massoud TF, Nolan DJ (1992) Dose reduction of hyoscine-N-butylbromide for double-contrast barium meal examinations - a prospective randomized study. Clin Radiol 46:340-343
12. Heron CW, Hine AL, Pozniak AL, Swinburn CR, Johnson NM (1985) Radiographic features in patients with pulmonary manifestations of the acquired immune deficiency syndrome. Clin Radiol 36:583-588
13. Hansen MB (2002) Small intestinal manometry. Physiol Res 51:541-556
14. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E (1998) Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 115:747-762
15. Nguyen HN, Silny J, Matern S (1999) Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: Current results and further implications. Am J Gastroenterol 94:306-317
16. Patak MA, Froehlich JM, von Weymarn C, Breitenstein S, Zollikofer CL, Wentz KU (2007) Non-invasive measurement of small-bowel motility by MRI after abdominal surgery. Gut 56:1023-1025
17. Dosda R, Marti-Bonmati L, Ronchera-Oms CL, Molla E, Arana E (2003) Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol 13:294-298